​We are delighted to congratulate our medical student, Sediga Nateqi, on the successful completion of her master’s thesis “The Potential of Antibody-Drug Conjugates in Biliary Tract Cancer” at the Phase 1 Unit, Rigshospitalet.

​Whole genome sequencing reveals additional insights and opportunities for precision treatment in brain tumor patients.

​Differences in Tumor Mutational Burden Assessment – Results from a National Ring Trial​

A new collaboration between Rigshospitalet, Zealand University Hospital and Siemens Healthineers aims to strengthen quality of care and health equity by bringing together public and private actors to develop solutions that work in practice.

Leaders and experts from the Nordic University Hospital Alliance (NUHA), representing the university hospitals of Oslo, Copenhagen, Stockholm, Helsinki and Reykjavík, gathered in Oslo on 4–5 May 2026 for the NUHA Annual Summit. 

​The 2026 edition of World’s Best Hospitals, published annually by Newsweek, places two Nordic hospitals among the global top fifteen, with Rigshospitalet – Copenhagen University Hospital at 15th place and Karolinska University Hospital at 4th place worldwide. It is an acknowledgement of the strong tradition for high‑quality, publicly funded healthcare in the Nordic region.

​Innovation District Copenhagen (IDC) has appointed Annemarie Munk Riis as its new Chief Executive Officer, taking up the position on June 1st 2026. She arrives directly from a position as CEO at Green Building Council and holds a degree in economics from the University of Copenhagen and a PhD from Copenhagen Business School. 

​Conducting large clinical studies and sharing research data between Sweden and Denmark is about to become easier. Rigshospitalet, Copenhagen University Hospital and Skåne University Hospital have signed a Memorandum of Understanding to facilitate cross-border collaboration and strengthen health innovation in the Öresund Region.

​New play installations at Mary Elizabeths Hospital, Aalborg University Hospital, and Sygehus Lillebælt will help children feel calmer and more confident before medical examinations. Nordea-fonden is funding the project with DKK 12.25 million.​

​In 2025, the Phase 1 Unit at Rigshospitalet continued to strengthen its position as a leading Nordic site for early-phase clinical research, supporting partners and sponsors in the efficient and safe development of innovative therapies.